Skip to main content

and
  1. Article

    Open Access

    Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome

    The gut microbiota influences many aspects of host physiology, including immune regulation, and is predictive of outcomes in cancer patients. However, whether conventional myelosuppressive chemotherapy affects...

    Lito E. Papanicolas, Sarah K. Sims, Steven L. Taylor, Sophie J. Miller in BMC Cancer (2021)